ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA

This adverse event was reported 314 times

These drugs are most commonly taken by patients reporting ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA:

# Drug Count
0 METHOTREXATE SODIUM 101
1 METHOTREXATE 78
2 PREDNISONE 50
3 CYCLOPHOSPHAMIDE 42
4 CYCLOPHOSPHAMIDE FOR INJECTION 42
5 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 42
6 ROMIDEPSIN 40
7 ADALIMUMAB 37
8 BRENTUXIMAB VEDOTIN 35
9 PREDNISOLONE 34
See all common drugs associated with ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA

ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ROMIDEPSIN 40 0.0237
1 BRENTUXIMAB VEDOTIN 35 0.0034
2 PRALATREXATE 2 0.0031
3 PALIFERMIN 1 0.0026
4 CIDOFOVIR ANHYDROUS 3 0.0021
5 PROBENECID 2 0.0017
6 SODIUM HYALURONATE 1 0.0012
7 DUVELISIB 1 0.0012
8 ACYCLOVIR SODIUM 1 0.0008
9 HYDROCORTISONE SODIUM SUCCINATE 3 0.0008
See all drugs enriched for association with ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA